CASE DISMISSED! Lawsuit against FDA over SSRI warning label is thrown out

Following her initial report on the lawsuit in May 2024 against the FDA for not responding to a 2018 citizen’s petition, Australian journalist Maryanne Demasi provides an update: the case has unfortunately been dismissed on a technicality. In her latest piece, Demasi sheds light on the ongoing challenges faced by people with PSSD and other harmed patient communities in getting their voices heard, as well as holding powerful institutions like the FDA accountable.